Abstract
We tested 10,715 low-risk pregnancies in a voluntary maternal serum α-fetoprotein screening program for the detection of neural tube defects in California. In all, 5.3 percent of women had one elevated serum level, 3.3 percent were referred for sonography and 1.5 percent for amniocentesis. There were 12 cases of open neural tube defects (1.1 per 1,000); all of the mothers had one elevated serum αfetoprotein level: nine (75 percent) completed the protocol and the neural tube defects were correctly identified. No normal pregnancies were terminated. The risk of an open neural tube defect occurring was about 1 in 50 after the first abnormal serum level and 1 in 15 at amniocentesis. We found significantly increased risk for fetal death and low birth weight after one elevated serum α-fetoprotein level, though the likelihood of a normal pregnancy outcome was about 80 percent. Maternal serum screening was also useful in identifying twin pregnancies and correcting underestimated gestational dates.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Althouse R., Wald N. Survival and handicap of infants with spina bifida. Arch Dis Child. 1980 Nov;55(11):845–850. doi: 10.1136/adc.55.11.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crandall B. F., Kasha W., Matsumoto M. Prenatal diagnosis of neural tube defects: experiences with acetylcholinesterase gel electrophoresis. Am J Med Genet. 1982 Jul;12(3):361–366. doi: 10.1002/ajmg.1320120314. [DOI] [PubMed] [Google Scholar]
- Creasy M. R., Alberman E. D. Congenital malformations of the central nervous system in spontaneous abortions. J Med Genet. 1976 Feb;13(1):9–16. doi: 10.1136/jmg.13.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laurence K. M. Effect of early surgery for spina bifida cystica on survival and quality of life. Lancet. 1974 Feb 23;1(7852):301–304. doi: 10.1016/s0140-6736(74)92606-3. [DOI] [PubMed] [Google Scholar]
- Layde P. M., von Allmen S. D., Oakley G. P., Jr Maternal serum alpha-fetoprotein screening: a cost-benefit analysis. Am J Public Health. 1979 Jun;69(6):566–573. doi: 10.2105/ajph.69.6.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lippman-Hand A., Fraser F. C., Biddle C. J. Inidcations for prenatal diagnosis in relatives of patients with neural tube defects. Obstet Gynecol. 1978 Jan;51(1):72–76. [PubMed] [Google Scholar]
- Macri J. N., Weiss R. R. Prenatal serum alpha-fetoprotein screening for neural tube defects. Obstet Gynecol. 1982 May;59(5):633–639. [PubMed] [Google Scholar]
- Sadovnick A. D., Baird P. A. A cost-benefit analysis of prenatal diagnosis for neural tube defects selectively offered to relatives of index cases. Am J Med Genet. 1982 May;12(1):63–73. doi: 10.1002/ajmg.1320120109. [DOI] [PubMed] [Google Scholar]
- Sever L. E., Sanders M., Monsen R. An epidemiologic study of neural tube defects in Los Angeles County I. Prevalence at birth based on multiple sources of case ascertainment. Teratology. 1982 Jun;25(3):315–321. doi: 10.1002/tera.1420250308. [DOI] [PubMed] [Google Scholar]
- Zackai E. H., Spielman R. S., Mellman W. J., Ames M., Bodurtha J. The risk of neural tube defects to first cousins of affected individuals. UCLA Forum Med Sci. 1978;20:99–102. [PubMed] [Google Scholar]